MEP of the week
Sirpa Pietikäinen, official European Parliament portrait

Member of the European Parliament · Finland EPP

Sirpa Pietikäinen

MEP for Finland · European People's Party · Kansallinen Kokoomus · official EP profile

Joined 1 December 2024ECONFEMM

As of 7 November 2026, Sirpa Pietikäinen (EPP, Finland) has declared 477 lobby meetings this term - rank 9 of 720 MEPs by declared meetings.

Sirpa Pietikäinen took the seat on 1 December 2024, so the term-wide average of 100 meetings per MEP and the ranks below cover a longer period than this record does; they are not a like-for-like comparison.

71% of this MEP's declared counterpart entries, including diplomatic and government entries, carry a declared EU Transparency Register link - above the like-for-like raw Parliament-wide share of 52%.

477
declared meetings
current term
962
records since 2016
full dataset
71%
all counterpart entries linked
incl. diplomacy; vs 52% EP‑wide
9/720
rank, all MEPs
joined 1 December 2024; not like‑for‑like
4/185
rank in EPP
joined 1 December 2024; not like‑for‑like

Compare with the rest: search and sort all 720 MEPs, or see every MEP from Finland.

Compared with the averages

Sirpa Pietikäinen, this term
477
Parliament average
100
EPP average
108

Transparency this term

Monthly declared meetings (bars) and the share of all counterpart entries carrying a declared Register link, including diplomatic and government entries (line), July 2024 to November 2026. This is the same current-term window as the figures above, beginning 16 July 2024. Sirpa Pietikäinen took the seat on 1 December 2024; the months before that are shaded, not counted as months without meetings.

Current month, partial through 6 Nov 2026: 0 declared meetings in Nov 2026. Peak: 48 in Jun 2025.

0%25%50%75%100%048July 2024: before taking the seatAugust 2024: before taking the seatSeptember 2024: before taking the seatOctober 2024: before taking the seatNovember 2024: before taking the seatDecember 2024: 0 declared meetingsJanuary 2025: 7 declared meetingsFebruary 2025: 32 declared meetingsMarch 2025: 43 declared meetingsApril 2025: 31 declared meetingsMay 2025: 25 declared meetingsJune 2025: 48 declared meetingsJuly 2025: 6 declared meetingsAugust 2025: 0 declared meetingsSeptember 2025: 38 declared meetingsOctober 2025: 31 declared meetingsNovember 2025: 33 declared meetingsDecember 2025: 15 declared meetingsJanuary 2026: 19 declared meetingsFebruary 2026: 23 declared meetingsMarch 2026: 23 declared meetingsApril 2026: 13 declared meetingsMay 2026: 14 declared meetingsJune 2026: 32 declared meetingsJuly 2026: 10 declared meetingsAugust 2026: 3 declared meetingsSeptember 2026: 20 declared meetingsOctober 2026: 11 declared meetingsNovember 2026: 0 declared meetingsnew termtook seatMonths with no declared meetings have no Register-share value; the dashes join the months either sideMonthly share of all counterpart entries carrying a declared Register link2024202520260%25%50%75%100%048July 2024: before taking the seatAugust 2024: before taking the seatSeptember 2024: before taking the seatOctober 2024: before taking the seatNovember 2024: before taking the seatDecember 2024: 0 declared meetingsJanuary 2025: 7 declared meetingsFebruary 2025: 32 declared meetingsMarch 2025: 43 declared meetingsApril 2025: 31 declared meetingsMay 2025: 25 declared meetingsJune 2025: 48 declared meetingsJuly 2025: 6 declared meetingsAugust 2025: 0 declared meetingsSeptember 2025: 38 declared meetingsOctober 2025: 31 declared meetingsNovember 2025: 33 declared meetingsDecember 2025: 15 declared meetingsJanuary 2026: 19 declared meetingsFebruary 2026: 23 declared meetingsMarch 2026: 23 declared meetingsApril 2026: 13 declared meetingsMay 2026: 14 declared meetingsJune 2026: 32 declared meetingsJuly 2026: 10 declared meetingsAugust 2026: 3 declared meetingsSeptember 2026: 20 declared meetingsOctober 2026: 11 declared meetingsNovember 2026: 0 declared meetingsnew termtook seatMonths with no declared meetings have no Register-share value; the dashes join the months either sideMonthly share of all counterpart entries carrying a declared Register link2024202520260%50%100%048took seat202420252026
declared meetings per month (left axis)all counterpart entries carrying a declared Register link; diplomacy included (right axis)
Show the figures for each monthHide the monthly figures
Declared meetings each month, and the share of all counterpart entries carrying a declared Register link.
MonthMeetingsLinked
Jul 2024 -
Nov 2024
not yet seated
Dec 20240-
Jan 2025771.4%
Feb 20253281.8%
Mar 20254375.6%
Apr 20253189.5%
May 20252571%
Jun 20254868%
Jul 2025666.7%
Aug 20250-
Sep 20253866.7%
Oct 20253174.3%
Nov 20253354.5%
Dec 20251560%
Jan 20261963.2%
Feb 20262365.2%
Mar 20262352.2%
Apr 20261376.9%
May 20261468.8%
Jun 20263266.7%
Jul 20261080%
Aug 2026366.7%
Sep 20262081.8%
Oct 20261190.9%
Nov 20260-

Busiest month: 48 declared in June 2025. Months with no declared meetings have no Register-share value; a dashed stretch of the line joins the months either side.

Who Sirpa Pietikäinen meets most

Counterparts are merged by resolved Transparency Register identity where possible. An entry counts as register-linked above only when the MEP declaration itself carries a Register link.

Where the meetings cluster

Both lists count this term. Sector pages count the full 2016–2026 record, and committee pages show each member's current-term total across all subjects, so their figures for this member can be higher.

Most-met sectors this term

Finance (114), Health & pharma (74), Environment & climate (33)

Meetings by committee topic this term

Economic and Monetary Affairs (134), Public Health (102), Environment, Climate and Food Safety (47), Women's Rights and Gender Equality (29)

Most recent declared meetings

DateCounterpartCapacitySubject
16 Oct 2026Lääke­teollisuus ry⁠↗MemberCurrent pharmaceutical policy
15 Oct 2026European Federation of Neurological Associations⁠↗Shadow rapporteurNeurological Health Strategy
15 Oct 2026European Coordination of Committees and Associations for Palestine⁠↗MemberCurrent situation in Palestine
8 Oct 2026Biogen⁠↗Shadow rapporteurNeurological Health Strategy
7 Oct 2026Reclaim Finance⁠↗MemberSFDR
6 Oct 2026Pharmaceutical Group of the European Union⁠↗MemberCurrent health policies
6 Oct 2026Alzheimer Europe⁠↗Shadow rapporteurNeurological Health Strategy
5 Oct 2026Deutsche Bank AG⁠↗MemberMISP
1 Oct 2026European Federation of Public Service UnionsMemberCare Deal
1 Oct 2026STTK ry⁠↗MemberCurrent equality and employment policies
Show 20 more meetingsShow fewer meetings
DateCounterpartCapacitySubject
1 Oct 2026The Goldman Sachs Group, Inc.⁠↗MemberMISP
30 Sep 2026Business Turku Oy⁠↗MemberWomen's Health
30 Sep 2026Akava ry⁠↗MemberCurrent equality and employment policies
30 Sep 2026Jerusalem Human Rights ConsortiumMemberCurrent situation in East Jerusalem
29 Sep 2026Väestöliitto - Family Federation of FinlandMemberEquality and women's rights
29 Sep 2026Nordea Bank Abp⁠↗MemberEU banking competitiveness
28 Sep 2026Save the Children Europe⁠↗MemberChildren's rights
28 Sep 2026Optiver⁠↗MemberMISP
25 Sep 2026European Midwives AssociationMemberCurrent European equality policies
14 Sep 2026Federation of European Securities Exchanges⁠↗MemberMISP
10 Sep 2026Oficina Internacional de Derechos Humanos - Acción Colombia⁠↗MemberHuman rights situation in Colombia
9 Sep 2026European Brain Council⁠↗; European Migraine and Headache Alliance⁠↗Shadow rapporteurNeurological Health Strategy
9 Sep 2026University of Eastern Finland Brain Research UnitShadow rapporteurNeurological health, neurodegenerative diseases, Alzheimer's, Neurological Health Strategy
9 Sep 2026Kiinteistön­omistajat ja rakennuttajat Rakli ry - Finnish Property Owners Rakli⁠↗MemberInfrastructure and housing investment
8 Sep 2026CSC – IT CENTER FOR SCIENCE LTD.⁠↗MemberEU economic policy
8 Sep 2026Chemical Industry Federation of Finland (Kemian­teollisuus ry)⁠↗MemberETS
7 Sep 2026The Bank of New York Mellon⁠↗; Strategic Advisory Management⁠↗MemberMISP
2 Sep 2026MyData Global ry⁠↗MemberFemale entrepreneurship
2 Sep 2026Equinet - the European Network of Equality Bodies⁠↗MemberEquality Bodies Directives
2 Sep 2026Eli Lilly and Company⁠↗Shadow rapporteurNeurological Health Strategy

The full record is in the official EP declarations.

Roll-call voting record

Recorded votes only. Parliament held 5,987 roll-call votes while Sirpa Pietikäinen held the seat, 558 of them the final vote on a text. A member with no vote recorded may have been on parliamentary business, ill, on leave, or present without voting - the published record does not distinguish these and gives no reason. Votes taken by show of hands or by secret ballot are not recorded by name and are absent here.

90%
roll-calls with a vote recorded
of 5,987 held while seated
491
final texts voted on
of 558
92%
voted with the EPP majority
on 487 final texts
40
differed from EPP
listed below

How they voted on final texts

Share of the 558 final votes held while seated.

Sirpa Pietikäinen558 final votes
82%12%
For 456Against 31Abstained 4No vote recorded 67

With and against the group

On the 487 final texts where more than half of EPP members casting a vote went one way, and Sirpa Pietikäinen also voted. Groups are not bound to vote together: a Member's mandate is personal and exercised freely, so neither figure is a measure of performance.

Voted with the EPP majority44792%
Voted differently408%

Final texts where Sirpa Pietikäinen differed from the EPP majority

DateTextTheir voteEPP majority
21 October 2026Motion for a resolution on the draft Commission implementing decision renewing the authorisation for placing on the market of products containing, consisting of or produced from genetically modified soybean MON 87769 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council B10-0469/2026 · Motion for a resolution (as a whole)ForAgainst
20 October 2026Motion for a resolution on the Commission delegated regulation of 9 July 2026 supplementing Regulation (EU) 2024/3012 of the European Parliament and of the Council by establishing the certification methodologies for carbon farming activities B10-0471/2026 · Motion for a resolutionForAgainst
8 October 2026Motion for a resolution on the draft Commission regulation amending Annex III to Regulation (EC) No 1925/2006 of the European Parliament and of the Council as regards monacolins from red yeast rice B10-0466/2026 · Motion for a resolutionAgainstFor
8 October 2026Motion for a resolution on the draft Commission regulation amending Annex III to Regulation (EC) No 1925/2006 of the European Parliament and of the Council as regards certain botanical species containing hydroxyanthracene derivatives B10-0465/2026 · Motion for a resolutionAgainstFor
8 October 2026Motion for a resolution on the need for an EU strategy to counter Islamist entryism and the influence of the Muslim Brotherhood network B10-0424/2026 · Motion for a resolution (as a whole)AgainstFor
8 July 2026Motion for a resolution on the Commission Implementing Decision renewing the authorisation for the placing on the market of products containing, consisting of or produced from genetically modified maize NK603 × T25 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council B10-0335/2026 · Motion for a resolution (as a whole)ForAgainst
8 July 2026Motion for a resolution on Commission delegated regulation of 10 April 2026 amending Commission Delegated Regulation (EU) 2019/807 to introduce a trajectory to gradually decrease the contribution of high indirect land-use change-risk biofuels, bioliquids and biomass fuels to renewable energy targets B10-0337/2026 · Motion for a resolution (as a whole)AgainstFor
8 July 2026Motion for a resolution on the draft Commission Implementing decision authorising the placing on the market of products containing, consisting of or produced from genetically modified maize DP202216 x NK603 x DAS-40278-9 and its sub-combinations DP202216 x NK603, DP202216 x DAS-40278-9, pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council B10-0336/2026 · Motion for a resolution (as a whole)ForAgainst
8 July 2026Motion for a resolution on the draft Commission implementing decision renewing the authorisation for the placing on the market of products containing, consisting of or produced from genetically modified soybean MON 87705 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council B10-0334/2026 · Motion for a resolution (as a whole)ForAgainst
17 June 2026Council directive on the structure and rates of excise duty applied to tobacco and tobacco related products (recast) A10-0161/2026 · Tomáš Kubín · Commission proposal to the CouncilAbstainedFor

30 further instances are not listed. All roll-call votes.

Unlinked but matchable

91 counterpart entries in Sirpa Pietikäinen's declarations appear to match an EU Transparency Register entry without being linked in the declaration:

These are the 3 most frequent matches, covering 7 of the 91 entries; the other 84 are not listed.

Matching is automated and can be wrong - see how matching works. Linking the register entry is the fix, and it is the MEP office's to make.